PLXND1
protein-codingplexin D1, the group of Plexins|IPT domain containing
Gene summary
Enables protein domain specific binding activity. Predicted to be involved in several processes, including positive regulation of axonogenesis; semaphorin-plexin signaling pathway; and synapse assembly. Predicted to act upstream of or within circulatory system development; dichotomous subdivision of terminal units involved in salivary gland branching; and kidney development. Located in lamellipodium. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~51.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008006
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008006
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0018072
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0859532
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0859532
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0859532
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859532
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008006
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PLXND1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015103.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 78 | 7 | 91 | ||
| missense | 4 | 301 | 21 | 8 | 334 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 4 | 6 | ||
| splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
| Total | 5 | 1 | 325 | 99 | 15 | 445 |
Highest pathogenic variant AF is 0.0000025611835
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055918.3 | 36 | MANE Select | |
| Ensembl | ENSP00000317128.4 | 36 | MANE Select | |
| Ensembl | ENSP00000426162.1 | 3 | Standard | |
| Ensembl | ENSP00000426241.2 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| plxnd1 | Danio rerio | Structure: fat cell Quality: increased process quality abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Angiogenesis overview
- miR-targeted genes in leukocytes - TarBase
- miR-targeted genes in lymphocytes - TarBase
- Developmental Biology
- Signal Transduction
Biological Process
- angiogenesis
- branching involved in blood vessel morphogenesis
- outflow tract morphogenesis
- cardiac septum development
- negative regulation of cell adhesion
Molecular Function
- protein binding
- semaphorin receptor activity
- protein domain specific binding
Cellular Component
- semaphorin receptor complex
- plasma membrane
- integral component of plasma membrane
- lamellipodium
- lamellipodium membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000324093
- Coding exons
- 36
- Length
- 51644
- Individuals with no LoFs
- 125727
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 21
- Defined
- 125748
- p
- 0.0000835
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.35 | 821 | 1.14e+3 | 0.721 | 0.0000733 | 12310 |
| Missense (PolyPhen) | 254 | 473.98 | 0.53588 | 5136 | ||
| Synonymous | 0.119 | 497 | 500 | 0.993 | 0.0000352 | 3922 |
| Loss of Function | 7.78 | 7 | 83.9 | 0.0835 | 0.00000415 | 920 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000089 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00040 | 0.00040 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000071 | 0.000070 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cell surface receptor for SEMA4A and for class 3 semaphorins, such as SEMA3A, SEMA3C and SEMA3E. Plays an important role in cell-cell signaling, and in regulating the migration of a wide spectrum of cell types. Regulates the migration of thymocytes in the medulla. Regulates endothelial cell migration. Plays an important role in ensuring the specificity of synapse formation. Required for normal development of the heart and vasculature (By similarity). Mediates anti-angiogenic signaling in response to SEMA3E. {ECO:0000250, ECO:0000269|PubMed:20385769}.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- LoFtool
- 0.160
- RVIS EVS
- -1.31
- RVIS percentile EVS
- 4.88
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.167
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |